Safusidenib

safusidenib · Nuvation Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Safusidenib, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) [Phase 3]